Stephen Raymond Self

Director & Development Director at e-Therapeutics Plc

Stephen Raymond Self

Stephen Raymond Self

Director & Development Director at e-Therapeutics Plc

Biography

Mr. Stephen R. Self was previously employed as Technical Director-Europe by Merck Generics and Head-Respiratory & Analgesic Product Development by Boots Healthcare International Ltd. He also served on the board at e-Therapeutics Plc.

Overview
RelSci Relationships

37

Number of Boards

1

Birthday

1955

Age

63

Relationships
RelSci Relationships are individuals Stephen Raymond Self likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Monograph LLP

Relationship likelihood: Strong

Former Chief Financial Officer at e-Therapeutics Plc

Relationship likelihood: Strong

Founder at e-Therapeutics Plc

Relationship likelihood: Strong

Finance Director & Executive Director at e-Therapeutics Plc

Relationship likelihood: Strong

Chairman at Biomer Technology Ltd.

Relationship likelihood: Strong

Former Executive Director, Director-Finance & Commercial at e-Therapeutics Plc

Relationship likelihood: Strong

Chief Executive Officer & Director at e-Therapeutics Plc

Relationship likelihood: Strong

Chief Financial Officer & Director at C4X Discovery Holdings Plc

Relationship likelihood: Strong

Senior Medical Advisor at The Penrose Group Ltd.

Relationship likelihood: Strong

Former Vice President-Translational & Early Drug Development at Celgene Corp.

Relationship likelihood: Average

Paths to Stephen Raymond Self
Potential Connections via
Relationship Science
You
Stephen Raymond Self
Director & Development Director at e-Therapeutics Plc
Career History
Director & Development Director
2010 - Current

e-Therapeutics Plc is a drug discovery and development company, which engages in the provision of evaluation services to investors and pharmaceutical companies. It focuses on the therapeutic immune-oncology, addressing drug resistance in targeted cancer therapies and antivirals. It offers the following variety of preclinical stage assets: ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule anti-TNFa; ETS2400, Hedgehog pathway inhibition; and ETS5200, broad spectrum antivirals together with two immuno-oncology checkpoint projects. The company was founded by Malcolm Philip Young on October 15, 2001 and is headquartered in Long Hanborough, the United Kingdom.

Technical Director-Europe
1997 - 2007
Head-Respiratory & Analgesic Product Development
1995 - Prior

Boots Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, UK

Boards & Committees
Executive Director
2010 - Prior

e-Therapeutics Plc is a drug discovery and development company, which engages in the provision of evaluation services to investors and pharmaceutical companies. The company focuses on the therapeutic immune-oncology, addressing drug resistance in targeted cancer therapies and antivirals. It offers the following variety of preclinical stage assets: ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule anti-TNFa; ETS2400, Hedgehog pathway inhibition; and ETS5200, broad spectrum antivirals together with two immuno-oncology checkpoint projects. The company was founded by Malcolm Philip Young on October 15, 2001 and is headquartered in Long Hanborough, the United Kingdom.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephen Raymond Self. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephen Raymond Self's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephen Raymond Self.